Communicating a robust economic strategy is paramount to device market success and often requires simplification into a budgetary impact model.
Value analysis committees (VAC) hear presentations from medtech companies routinely and yours must stand out clearly.
If you can simplify your economic message, for rapid understanding by your clinical champion and the VAC, your medtech organization is one step closer to receiving approval to sell in that healthcare institution.
Below is a generic budgetary impact model we have developed to share with clients interested in seeing a Medi-Vantage budgetary impact model.
Simplification is the key, to allow all stakeholders to understand the context of the economic claims of your device. Then, if the claims for your device resonate with the economic buyer, your sales representative has the opportunity to share his/her expertise and to present the data supporting the device’s economic value proposition.
CONTACT US
LOOKING FOR A PARTNER WITH MEDICAL DEVICE M&A STRATEGY EXPERTISE WITH CLINICIANS, HOSPITAL ADMINISTRATORS AND HOSPITAL CFOS?
OUR LAST 4 PROJECTS:
Budgetary impact model development for a start up in orthopedics
M & A due diligence for a mid-market tuck in
Medtech price sensitivity analysis
Price Strategy & Budgetary Impact Model Development for a novel and disruptive medtech product